Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Adams

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
BMJ Open|September 28, 2022
Peer Reviewed Evaluation of Registered End-Points of Randomised Trials (the PRE-REPORT study): a stepped wedge, cluster-randomised trialChristopher W Jones, Amanda Adams, Benjamin S Misemer, et al.
Brain and Behavior|June 27, 2023
Development and clinical feasibility study of a brief version of an addiction-focused phenotyping battery in females receiving buprenorphine for opioid use disorderAnna Beth Parlier-Ahmad, Michelle Eglovitch, Catherine Legge, et al.
Annals of Surgical Oncology|September 21, 2021
What to do When Decompressive Gastrostomies and Jejunostomies are not Options? A Scoping Review of Transesophageal Gastrostomy Tubes for Advanced MalignanciesClara Zhu, Rebecca Platoff, Gaby Ghobrial, et al.
Expert Opinion on Pharmacotherapy|December 4, 2009
Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trialsRoger S McIntyre, David J Muzina, Amanda Adams, et al.
CNS Drugs|September 3, 2010
The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implicationsRoger S McIntyre, Ka Young Park, Candy W Y Law, et al.
BMJ Open Respiratory Research|March 6, 2026
Phase 2a randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of londamocitinib (AZD4604) two times per day for 12 weeks in adult patients with moderate-to-severe asthma uncontrolled on medium-high-dose ICS-LABAMohd Nubli Mustapa, Rod Hughes, Tina J Jensen, et al.
JAMA|April 5, 2012
Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer riskWendie A Berg, Zheng Zhang, Daniel Lehrer, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
BMJ Open|September 28, 2022
Peer Reviewed Evaluation of Registered End-Points of Randomised Trials (the PRE-REPORT study): a stepped wedge, cluster-randomised trialChristopher W Jones, Amanda Adams, Benjamin S Misemer, et al.
Brain and Behavior|June 27, 2023
Development and clinical feasibility study of a brief version of an addiction-focused phenotyping battery in females receiving buprenorphine for opioid use disorderAnna Beth Parlier-Ahmad, Michelle Eglovitch, Catherine Legge, et al.
Annals of Surgical Oncology|September 21, 2021
What to do When Decompressive Gastrostomies and Jejunostomies are not Options? A Scoping Review of Transesophageal Gastrostomy Tubes for Advanced MalignanciesClara Zhu, Rebecca Platoff, Gaby Ghobrial, et al.
Expert Opinion on Pharmacotherapy|December 4, 2009
Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trialsRoger S McIntyre, David J Muzina, Amanda Adams, et al.
CNS Drugs|September 3, 2010
The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implicationsRoger S McIntyre, Ka Young Park, Candy W Y Law, et al.
BMJ Open Respiratory Research|March 6, 2026
Phase 2a randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of londamocitinib (AZD4604) two times per day for 12 weeks in adult patients with moderate-to-severe asthma uncontrolled on medium-high-dose ICS-LABAMohd Nubli Mustapa, Rod Hughes, Tina J Jensen, et al.
JAMA|April 5, 2012
Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer riskWendie A Berg, Zheng Zhang, Daniel Lehrer, et al.
Pageof 4